Iohexol: Side Effects, Uses & Monitoring
Oraltag is indicated for use in computed tomography of the abdomen and pelvis to opacify bowel loops and delineate between normal loops and adjacent organs or areas of suspected pathology.
- Data source
- FDA labeling via NIH DailyMed (label fdeb1668…)
- Label version
- current
- Last reviewed
- 2026
Reported adverse reactions
Reactions listed in current FDA labeling, with the highest frequency reported across summarized placebo-controlled trials.
No structured frequency data available in current labeling. Consult the official label.
Labeled uses (from FDA prescribing information)
Oraltag is indicated for use in computed tomography of the abdomen and pelvis to opacify bowel loops and delineate between normal loops and adjacent organs or areas of suspected pathology. Limitations of Use Oraltag is not indicated for diagnostic examination of the gastrointestinal tract.
Frequently Asked Questions
What is Iohexol used for?
FDA labeling lists the approved uses shown above under "Labeled uses." This summary is informational; only a qualified prescriber can determine whether a medication is appropriate for you.
What are the most commonly reported side effects of Iohexol?
Current labeling for this ingredient does not include a structured frequency table that we can reproduce. Review the official label linked below.
Does Iohexol require lab monitoring?
Monitoring needs vary. Ask your healthcare provider whether any lab tests apply while taking Iohexol.
Where does this information come from?
All clinical facts on this page were extracted from the current FDA-registered product labeling for this ingredient, published by manufacturers through NIH DailyMed. See the source link below.
Medical disclaimer: Educational content extracted from public FDA labeling. Not medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.